Aneuvo Biomedical

Aneuvo is a medical technology company focused on developing non-invasive neuromodulation therapies for individuals with spinal cord injuries and other neurological disorders. The company's flagship platform, the ExaStim system, utilizes transcutaneous spinal cord stimulation (tSCS) to activate spinal circuits and facilitate functional recovery. Aneuvo is currently advancing its lead program through the ATLAS pivotal clinical trial, which evaluates the system's efficacy in restoring upper limb function in chronic spinal cord injury patients. Headquartered in California, the company leverages licensed technology from UCLA to bridge the gap between clinical research and commercial neurorehabilitation solutions.